Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2022  |  Volume : 20  |  Issue : 2  |  Page : 107-108

Use of prasugrel in patients with clopidogrel hypersensitivity

1 Department of Cardiology, Coronary Care Unit, BLK Hospital, New Delhi, India
2 Hima Bindu Hospital, Hyderabad, Telangana, India

Correspondence Address:
Dr. Darpanarayan Hazra
Department of Cardiology, Coronary Care Unit, BLK Hospital, Pusa Road, Radha Soami Satsang, Rajendra Place, New Delhi - 110 005
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/cmi.cmi_19_22

Rights and Permissions

Allergic response to clopidogrel is a significant and difficult clinical problem as it is one of the recommended drugs after coronary stenting to prevent thrombosis. We present the case of a 57-year-old man who underwent coronary revascularization and developed an urticarial rash after being started on dual antiplatelet medication (aspirin and clopidogrel). He was managed conservatively, to which he responded well and was discharged on prasugrel. This case study from India adds to the available literature and discusses the alternative drugs that could be used in patients with clopidogrel hypersensitivity.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded66    
    Comments [Add]    

Recommend this journal